ClinicalTrials.Veeva

Menu

The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis

R

Rambam Health Care Campus

Status

Unknown

Conditions

Cytomegalovirus
Herpesvirus Infection
Epstein-Barr Virus Infections

Study type

Observational

Funder types

Other

Identifiers

NCT01248598
400-10-RMB CTIL

Details and patient eligibility

About

The purpose of this study is to study the prevalence of EBV, HCMV, HHV-6 in saliva and on the toothbrush patient with periodontitis.

Full description

Human cytomegalovirus (HCMV), Epstein-Barr virus (EBV) Human Herpes virus6 (HHV-6)

Enrollment

10 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with peridontitis

Exclusion criteria

  • Previous periodontal treatment in last 3 month
  • Toothbrushing disability

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems